A broader cardiac picture
A wearable 6/12-lead design is built to capture more of the heart’s electrical activity than 1–2 lead wearables.
LifePath-C · United States
Designed for greater cardiac visibility.
LifePath-C is a wearable 6/12-lead ambulatory ECG monitoring platform being developed to combine continuous monitoring, broader cardiac visibility, and connected review workflows within a single system.
- Status
- Under FDA 510(k) review
The challenge
A short clinic ECG captures only a moment.
LifePath-C is being developed as a medical device to support ambulatory cardiac monitoring outside the clinic, providing longitudinal visibility that a brief in-clinic ECG or limited-duration recording may not provide.
Developed as a medical device (IEC 60601 series, ISO 10993, SBOM/threat-modelling posture).
One patient, one year
Seen in clinic
A handful of appointments. Everything between them is unobserved.
Monitored continuously
The same year, with the stretches in between actually covered.
What it’s designed to do
Continuous ambulatory monitoring, built for clinical review.
Catches what a moment can miss
Continuous ambulatory monitoring is designed for longitudinal capture outside the clinic, not a 10-second clinic ECG or a single-day recording read after the fact.
Structured clinical review
The platform is designed to organize ambulatory recordings and support the clinical review workflow.
Clinician-controlled review
The platform routes recordings for review by the institution’s clinical team. (Elastic Care-operated monitoring is not offered for US deployments.)
Compact and comfortable by design
Engineered to be small and unobtrusive, designed around patient comfort and discreet, everyday wear, without compromising signal quality or clinical fidelity.
Built as a medical device
Developed with attention to safety, usability, cybersecurity, software validation, and risk management.
Regulatory status
LifePath-C is currently under FDA 510(k) review. It is not currently FDA-cleared for commercial distribution in the United States.
Follow LifePath-C.
For partnership or investor inquiries, or to be notified about future availability, get in touch.
Contact usLifePath RPM is cleared by the FDA under 510(k). LifePath-C is currently under FDA 510(k) review and is not available for sale or clinical use in the United States. Elastic Care-managed monitoring services are currently available only in select international markets and may not be available in all jurisdictions. Product availability, indications for use, and detection capabilities vary by jurisdiction and are subject to local clearance or licensing. Information on this site is for general informational purposes and is not medical advice.